@article{a2baae087acd4f2d8e948c9d6b72a8a0,
title = "Wound drainage measurements: a narrative review",
abstract = "Drainage from chronic wounds can significantly negatively impact a patient{\textquoteright}s quality of life. Change in severity of wound drainage is an important measure of treatment efficacy for wounds. This study reviews existing tools used to assess wound drainage. Qualitative drainage tools are overall less burdensome, and however, differences in user interpretation may reduce inter-rater reliability. Quantitative drainage tools enable more reliable comparisons of drainage severity and treatment response between patients but sometimes require equipment to administer, increasing responder burden. Gaps in the current wound drainage measurement landscape are highlighted. Many of the existing scales have not been validated in robust studies. There is also a lack of validated global drainage measurement tools for patients with chronic inflammatory skin disorders with drainage, such as hidradenitis suppurativa or pyoderma gangrenosum. Development of a succinct drainage measurement tool for inflammatory skin diseases where drainage is a prominent symptom will improve monitoring of meaningful treatment response.",
author = "Terri Shih and Sarah Park and Thorlacius, {Linnea R.} and Steven Daveluy and Amit Garg and Goegji, {Susanne D.} and Kirby, {Joslyn S.} and McGrath, {Barry M.} and Riis, {Peter T.} and Bente Villumsen and Kari Zalik and Jemec, {Gregor B.E.} and Hsiao, {Jennifer L.}",
note = "Funding Information: JLH is on the Board of Directors for the Hidradenitis Suppurativa Foundation, has served as a consultant for Boehringer Ingelheim, Novartis, and UCB, and has served as a consultant and speaker for AbbVie. LT reports personal fees from UCB, non-financial support from AbbVie and Janssen-Cilag, grants from Regeneron, and is co-copyright holder of HiSQOL. SD is on the Board of Directors for the Hidradenitis Suppurativa Foundation, has served as an investigator for AbbVie, Pfizer, Novartis, and UCB, and has served as a consultant and speaker for AbbVie. AG is an advisor for AbbVie, Aclaris Therapeutics, Anaptys Bio, Aristea Therapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Incyte, InflaRx, Insmed, Janssen, Novartis, Pfizer, UCB, Union Therapeutics, and Viela Biosciences, and receives honoraria. AG receives research grants from AbbVie, UCB and National Psoriasis Foundation. AG receives research grants from AbbVie, UCB, and National Psoriasis Foundation. AG is co-copyright holder of the HS-IGA and HiSQOL instruments. JSK is the President of the Hidradenitis Suppurativa Foundation. AbbVie: Consultant, Speaker, Advisory Board (Honoraria), ChemoCentryx, Incyte, Janssen, Novartis, UCB: Consultant (Honoraria). BMG has received fees from Novartis. GBJ reports grants and personal fees from AbbVie, personal fees from Coloplast, personal fees from Chemocentryx, personal fees from LEO pharma, grants from LEO Foundation, grants from Afyx, personal fees from Incyte, grants and personal fees from InflaRx, grants from Janssen-Cilag, grants and personal fees from Novartis, grants and personal fees from UCB, grants from CSL Behring, grants from Regeneron, grants from Sanofi, personal fees from Kymera, personal fees from VielaBio, outside the submitted work. There was no financial transaction for the preparation of this manuscript. All other authors report no conflicts of interest. Publisher Copyright: {\textcopyright} 2023, The Author(s).",
year = "2023",
month = sep,
doi = "10.1007/s00403-023-02525-5",
language = "English (US)",
volume = "315",
pages = "1863--1874",
journal = "Archives of Dermatological Research",
issn = "0340-3696",
publisher = "Springer Verlag",
number = "7",
}